Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/2012
06/21/2012WO2012027555A3 Glycated cd59 peptides, their preparation, and uses thereof
06/21/2012WO2012027514A3 Compositions and methods for cardiac therapy
06/21/2012WO2012026820A3 Immunotherapeutic method for treating prostate cancer
06/21/2012WO2012021512A3 Erythrocyte-binding therapeutics
06/21/2012US20120159661 T-Bet Compositions and Methods of Use Thereof
06/21/2012US20120159659 Custom-made meganuclease and use thereof
06/21/2012US20120157976 Methods for treating neurological conditions and compositions and materials therefor
06/21/2012US20120157917 High pressure delivery system and method for treating pelvic disorder using large molecule therapeutics
06/21/2012US20120157395 Anti-inflammatory agent for oral application, and anti-inflammatory peptide for oral application
06/21/2012US20120157394 Selective caspase inhibitors and uses thereof
06/21/2012US20120157393 Biopolymer, implant comprising it and uses thereof
06/21/2012US20120157392 Epilepsy treatment employing ketogenic compounds which arrest apoptosis
06/21/2012US20120157390 IAP Inhibitors
06/21/2012US20120157389 Peptides for treating cancer
06/21/2012US20120157387 Orally bioavailable d-gamma-glutamyl-d-tryptophan
06/21/2012US20120157386 Neprilysin inhibitors
06/21/2012US20120157385 Cyclosporin conjugates
06/21/2012US20120157384 Mutants pf4 polypeptides exhibiting an increased anti-angiogenic activity
06/21/2012US20120157383 Neprilysin inhibitors
06/21/2012US20120157382 Pharmaceutical glp-1 compositions having an improved release profile
06/21/2012US20120157381 Compositions and methods for cardiac tissue repair
06/21/2012US20120157380 Pegylated human apoa-1 and process for production thereof
06/21/2012US20120157379 Gastric Inhibitory Peptide Variants and Their Uses
06/21/2012US20120157378 Methods and Compositions for Predicting a Subject's Susceptibility To and Risk of Developing Type 2 Diabetes
06/21/2012US20120157377 Methods to enhance night vision and treatment of night blindness
06/21/2012US20120157376 Pharmacologically active antiviral peptides and methods of their use
06/21/2012US20120157375 Identification of Inhibitors of a Bacterial Stress Response
06/21/2012US20120157374 Nodule specific medicago peptides having antimicrobial activity and pharmaceutical compositions containging the same
06/21/2012US20120157373 Antimicrobial compounds having protective or therapeutic leaving groups
06/21/2012US20120157372 Human milk peptides
06/21/2012US20120157371 High penetration prodrug compositions of antimicrobials and antimicrobial-related compounds
06/21/2012US20120156732 Useful polypeptides
06/21/2012US20120156722 Tumor Suppressor Gene
06/21/2012US20120156649 Methods for treating dental diseases, disorders, and injuries
06/21/2012US20120156306 Viral inactivated platelet extract, use and preparation thereof
06/21/2012US20120156305 Methods for enhancing genome stability and telomere elongation in embryonic stem cells
06/21/2012US20120156304 Branched polyol polyesters, blends, and pharmaceutical formulations comprising same
06/21/2012US20120156295 Antibiotic compounds
06/21/2012US20120156289 Biodegradable Osmotic Pump Implant For Drug Delivery
06/21/2012US20120156287 Use of Vitelline Protein B as a Microencapsulating Additive
06/21/2012US20120156284 Enhanced biological autologous tissue adhesive composition and methods of preparation and use
06/21/2012US20120156276 Connective tissue stimulating peptides
06/21/2012US20120156265 Conformable tissue repair implant capable of injection delivery
06/21/2012US20120156259 Biodegradable Polyethylene Glycol Based Water-Insoluble Hydrogels
06/21/2012US20120156254 Recombinant laminin-521
06/21/2012US20120156253 Enzyme Treatment of Foodstuffs for Celiac Sprue
06/21/2012US20120156250 Compositions and methods for cardiac therapy
06/21/2012US20120156246 Reprogramming cancer cells
06/21/2012US20120156244 Nasal Compositions and Uses Thereof
06/21/2012US20120156237 Novel Antitoxin and Vaccine Platform Based on Nodavirus VLPS
06/21/2012US20120156236 Neisseria meningitidis antigens and compositions
06/21/2012US20120156235 Antibodies Against And Methods For Producing Vaccines For Respiratory Syncytial Virus
06/21/2012US20120156234 Means for treating synucleinopathies
06/21/2012US20120156226 Marker Differentially Expressed in Cancer Stem Cells and Methods of Using Same
06/21/2012US20120156222 Prevention and treatment of alzheimer's disease
06/21/2012US20120156221 Method and Pharmaceutical Composition for Use in the Treatment of Neurodegenerative Disorders
06/21/2012US20120156214 Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseases
06/21/2012US20120156213 Method for treating th17 inflammatory disease through inhibition of vascular endothelial growth factor receptors and pharmaceutical composition therefor
06/21/2012US20120156209 Anti-il-tif antibodies and methods of use
06/21/2012US20120156202 Age related macular degeneration treatment
06/21/2012US20120156195 Human-Murine Chimeric Antibodies Against Respiratory Syncytial Virus
06/21/2012US20120156188 Chemical method for sexual sterilization and libido elimination in male mammals
06/21/2012US20120156187 Methods and compositions for modulation of blood-neural barrier
06/21/2012US20120156186 Non-cytotoxic protein conjugates
06/21/2012US20120156183 Sorcs1-like agent for use in the treatment of insulin resistance and diseases related thereto
06/21/2012US20120156180 Compositions and methods for the treatment of krabbe and other neurodegenerative diseases
06/21/2012US20120156179 Method for inducing extended self-renewal of functionally differentiated somatic cells
06/21/2012US20120156178 Treatment of peyronies disease
06/21/2012US20120156176 Thermoresponsive, biodegradable, elastomeric material and uses therefor
06/21/2012US20120156175 Composition for inducing migration of neural stem cells containing periostin as effective ingredient
06/21/2012US20120156166 Inhibitors of flaviviridae viruses
06/21/2012US20120156164 In situ-forming hydrogel for tissue adhesives and biomedical use thereof
06/21/2012US20120156143 Dosage forms of plant-derived cathartics
06/21/2012US20120156138 Methods and Compositions for the Treatment of Medical Conditions Involving Cellular Reprogramming
06/21/2012US20120156134 Compositions and methods for detecting or eliminating senescent cells to diagnose or treat disease
06/21/2012US20120156132 Targeting agent to newly formed blood vessels
06/21/2012US20120155620 Personal-Call and Feature Control System and Method for Controlling Telephones, Providing Extended Features for Such Telephones and Routing of Media-Rich Calls
06/21/2012CA2826252A1 Recombinant laminin-521
06/21/2012CA2821952A1 Melanoma treatments
06/21/2012CA2821945A1 Aqueous factor viii solution
06/21/2012CA2821908A1 Novel biomarker and uses thereof in diagnosis, treatment of autism
06/21/2012CA2821886A1 Solid compositions comprising a glp-1 agonist and a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid
06/21/2012CA2821715A1 Chimeric fibronectin matrix mimetics and uses thereof
06/21/2012CA2821613A1 Preparation comprising insulin, nicotinamide and an amino acid
06/21/2012CA2821244A1 Therapeutic agent for disc herniation
06/21/2012CA2821223A1 Novel therapeutic strategies for improving an anticancer treatment
06/21/2012CA2821141A1 Nanoparticles comprising at least one active agent and at least two polyelectrolytes
06/21/2012CA2821009A1 Cyclosporine analogue molecules modified at amino acid 1 and 3
06/21/2012CA2820871A1 Disease inhibiting agent
06/21/2012CA2819426A1 Combination therapy comprising vemurafenib and an interferon for use in the treatment of cancer
06/21/2012CA2819167A1 Pharmaceutical compositions comprising alisporivir
06/20/2012EP2465944A1 Method for identifying functional cytokine memory via analysis of DNA methylation
06/20/2012EP2465935A2 Recombinant human interferon-like proteins
06/20/2012EP2465931A1 Light-receiving channel rhodopsin having improved expression efficiency
06/20/2012EP2465928A1 Treatment of Th17-mediated diseases
06/20/2012EP2465579A1 Methods to reduce oxalate concentration by administration of oxalate oxidase crystals
06/20/2012EP2465538A2 Use of immunesuppressant receptor
06/20/2012EP2465537A1 Microspheres comprising ONO-1301
06/20/2012EP2465535A1 Methods for treating conditions associated with MASP-2 dependent complement activation
06/20/2012EP2465534A1 Methods for treating conditions associated with MASP-2 dependent complement activation
1 ... 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 ... 3163